This study also highlighted the efficacy of the GLUT5 inhibitor MSNBA, which significantly reduced colon cancer cell viability and inhibited cancer growth without adversely affecting healthy cells (Fig. 3). The gene discussed is SLC2A5; the disease is cancer.